HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression.

Abstract
Induction of phase 2 detoxification enzymes by phenolic antioxidants can account for prevention of tumor initiation but cannot explain why these compounds inhibit tumor promotion. Phase 2 genes are induced through an antioxidant response element (ARE). Although the ARE resembles an AP-1 binding site, we show that the major ARE binding and activating protein is not AP-1. Interestingly, AP-1 DNA binding activity was induced by the phenolic antioxidant tert-butylhydroquinone (BHQ), but the induction of AP-1 transcriptional activity by the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) was inhibited by this compound. BHQ induced expression of c-jun, junB, fra-1, and fra-2, which encode AP-1 components, but was a poor inducer of c-fos and had no effect on fosB. Like c-Fos and FosB, the Fra proteins heterodimerize with Jun proteins to form stable AP-1 complexes. However, Fra-containing AP-1 complexes have low transactivation potential. Furthermore, Fra-1 repressed AP-1 activity induced by either TPA or expression of c-Jun and c-Fos. We therefore conclude that inhibitory AP-1 complexes composed of Jun-Fra heterodimers, induced by BHQ, antagonize the transcriptional effects of the tumor promoter TPA, which are mediated by Jun-Fos heterodimers. Since AP-1 is an important mediator of tumor promoter action, these findings may explain the anti-tumor-promoting activity of phenolic antioxidants.
AuthorsK Yoshioka, T Deng, M Cavigelli, M Karin
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 92 Issue 11 Pg. 4972-6 (May 23 1995) ISSN: 0027-8424 [Print] United States
PMID7761434 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anticarcinogenic Agents
  • Antioxidants
  • DNA-Binding Proteins
  • FOSL2 protein, human
  • Fos-Related Antigen-2
  • Fosl2 protein, mouse
  • Hydroquinones
  • Oligonucleotide Probes
  • Proto-Oncogene Proteins c-fos
  • Transcription Factor AP-1
  • Transcription Factors
  • fos-related antigen 1
  • 2-tert-butylhydroquinone
  • Tetradecanoylphorbol Acetate
Topics
  • Animals
  • Anticarcinogenic Agents (pharmacology)
  • Antioxidants (pharmacology)
  • Base Sequence
  • DNA-Binding Proteins (biosynthesis)
  • Fos-Related Antigen-2
  • Gene Expression (drug effects)
  • Genes, fos (drug effects)
  • Genes, jun (drug effects)
  • HeLa Cells
  • Humans
  • Hydroquinones (pharmacology)
  • Mice
  • Molecular Sequence Data
  • Oligonucleotide Probes
  • Oxidation-Reduction
  • Proto-Oncogene Proteins c-fos (biosynthesis)
  • Proto-Oncogenes (drug effects)
  • Tetradecanoylphorbol Acetate (pharmacology)
  • Transcription Factor AP-1 (antagonists & inhibitors)
  • Transcription Factors (biosynthesis)
  • Transcription, Genetic
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: